← Back to LSTA

Lisata Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 11/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 11/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 08/05/2025
$0$0$0$0.1$0$0$0$0
−$2.9−$4.5−$4.2−$4.7−$4.7−$4.9−$5−$5.4
−$0.32−$0.50−$0.49−$0.54−$0.55−$0.59−$0.61−$0.65
9.198.78.68.68.38.38.3

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.